Clinical Trial Update: Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma [Phase 2]

View source ↗

Summary

Clinical trial update reports results from a Phase 2 study of thalidomide plus temozolomide in relapsed or progressive pediatric central nervous system tumors a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Neuroblastoma

Drugs mentioned

• Temodar (Temozolomide)
• Thalomid (thalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Central Nervous System Tumor, Pediatric, Neuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-25